# MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
> **ANDA216901** · Abbreviated New Drug Application (Generic) · Sponsor: XIAMEN LP PHARM CO · Approved 2025-07-15
## Drug
- **FDA Application Number:** ANDA216901
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
- **Generic name:** MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
- **Active ingredients:** DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIAMEN LP PHARM CO
- **Manufacturer:** Vitruvias Therapeutics, Inc.
- **First approval:** 2025-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216901)
---
*AI Analytics · CC0 1.0*